Beyond the Solution
The Latest News from the New Frontier of Pharma
Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector
Under the grant, researchers from the University's Center for Drug Design, College of Pharmacy, and Massachusetts-based pharmaceutical company Windgap Medical are collaborating to design an autoinjector.
Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector
Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S ("ALK") to commercialize the company's epinephrine autoinjector (EAI) for the treatment of anaphylactic shock.
Windgap Medical Announces Strategic Investment from Molex Ventures
Windgap Medical, Inc. announced today that it has finalized a deal to enable a strategic investment from Molex Ventures, LLC, a subsidiary of Koch Industries ("Molex Ventures").
Massachusetts Life Sciences Center Board Approves New Round of Accelerator Program Loans
Announces next round of Life Sciences Accelerator Loan Program